Genoray Co., Ltd. (KOSDAQ:122310)
3,340.00
-130.00 (-3.75%)
At close: Jun 19, 2026
Genoray Market Cap
Genoray has a market cap or net worth of 40.57 billion as of June 18, 2026. Its market cap has decreased by -44.63% in one year.
Market Cap
40.57B
Enterprise Value
55.07B
Revenue
108.27B
Ranking
n/a
PE Ratio
186.40
Stock Price
3,340.00
Market Cap Chart
Since May 28, 2018, Genoray's market cap has decreased from 150.47B to 40.57B, a decrease of -73.04%. That is a compound annual growth rate of -15.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 40.57B | -19.71% |
| Dec 30, 2025 | 50.53B | -27.84% |
| Dec 30, 2024 | 70.03B | -26.75% |
| Dec 28, 2023 | 95.60B | -11.63% |
| Dec 29, 2022 | 108.18B | -23.55% |
| Dec 30, 2021 | 141.51B | 1.54% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| May 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dynamic solution | 78.99B |
| SELVAS Healthcare | 78.82B |
| DRGEM | 55.79B |
| QuantaMatrix | 52.85B |
| JPI Healthcare | 41.05B |
| Noul Co.,Ltd. | 37.03B |
| UXN Co., Ltd. | 34.13B |
| MEKICS CO., | 32.08B |